Taken together, these findings indicate that PD-1/PD-L1 activity in immune cells is dependent on STAT1 expression by tumour cells during HNSCC but may be independent of STAT1 expression by immune cells. The gene discussed is STAT1; the disease is head and neck squamous cell carcinoma.